Genenta Science Future Growth
Future criteria checks 0/6
Genenta Science is forecast to grow earnings and revenue by 50.6% and 74.8% per annum respectively while EPS is expected to grow by 48.1% per annum.
Key information
50.6%
Earnings growth rate
48.1%
EPS growth rate
| Biotechs earnings growth | 25.1% |
| Revenue growth rate | 74.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 10 May 2024 |
Recent future growth updates
No updates
Recent updates
We're Keeping An Eye On Genenta Science's (NASDAQ:GNTA) Cash Burn Rate
Jan 26
We're Hopeful That Genenta Science (NASDAQ:GNTA) Will Use Its Cash Wisely
Jul 21We're Not Worried About Genenta Science's (NASDAQ:GNTA) Cash Burn
Dec 10We're Hopeful That Genenta Science (NASDAQ:GNTA) Will Use Its Cash Wisely
Sep 09Gene therapy developer Genenta Science named a buy at Wainwright on tumor approach
Jul 25Is Genenta Science (NASDAQ:GNTA) In A Good Position To Invest In Growth?
Mar 18Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -30 | N/A | N/A | 2 |
| 12/31/2025 | N/A | -24 | N/A | N/A | 2 |
| 12/31/2024 | N/A | -18 | N/A | N/A | 2 |
| 12/31/2023 | N/A | -12 | -11 | -11 | N/A |
| 9/30/2023 | N/A | -12 | -12 | -12 | N/A |
| 6/30/2023 | N/A | -13 | -12 | -12 | N/A |
| 3/31/2023 | N/A | -11 | -10 | -10 | N/A |
| 12/31/2022 | N/A | -8 | -7 | -7 | N/A |
| 9/30/2022 | N/A | -6 | -6 | -6 | N/A |
| 6/30/2022 | N/A | -4 | -5 | -5 | N/A |
| 3/31/2022 | N/A | -5 | -6 | -6 | N/A |
| 12/31/2021 | N/A | -6 | -7 | -7 | N/A |
| 9/30/2021 | N/A | -6 | -8 | -8 | N/A |
| 6/30/2021 | N/A | -7 | -9 | -9 | N/A |
| 3/31/2021 | N/A | -6 | -7 | -7 | N/A |
| 12/31/2020 | N/A | -6 | -6 | -6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GNTA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: GNTA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: GNTA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: GNTA is forecast to have no revenue next year.
High Growth Revenue: GNTA is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GNTA's Return on Equity is forecast to be high in 3 years time